M. Bonfanti

TECHNOLOGY ASSESSMENT IN HOSPITALS: LESSONS LEARNED FROM AN EMPIRICAL EXPERIMENT

R. Manzini, E. Lettieri, C. Masella, 2017, International Journal of Technology Assessment in Health Care.

Cost-effectiveness analysis of dolutegravir plus backbone compared with raltegravir plus backbone, darunavir+ritonavir plus backbone and efavirenz/tenofovir/emtricitabine in treatment naïve and experienced HIV-positive patients

A. Lazzarin, A. Antinori, U. Restelli, 2017, Therapeutics and clinical risk management.

Financial and feasibility implications of the treatment of hepatitis C virus in Italy: scenarios and perspectives

U. Restelli, D. Croce, M. Bonfanti, 2016, ClinicoEconomics and outcomes research : CEOR.

Budget impact analysis of the use of daclatasvir in Italy for the treatment of Hepatitis C Virus (HCV) genotype 3 patients

C. Nappi, A. Lazzarin, A. Alberti, 2016 .

Organisational and financial consequences of the early discharge of patients treated for acute bacterial skin and skin structure infection and osteomyelitis in infectious disease departments in Greece, Italy and Spain: a scenario analysis

A. Gray, U. Restelli, Valeria Pacelli, 2019, BMJ Open.

A cost analysis of inherited colorectal cancer care in Varese Province

F. Sessa, C. Capella, D. Croce, 2016 .

Real-world economic burden of venous thromboembolism and antithrombotic prophylaxis in medical inpatients.

W. Ageno, E. Foglia, E. Porazzi, 2013, Thrombosis research.

Cost of illness of Primary Biliary Cholangitis - a population-based study.

M. Carbone, U. Restelli, D. Croce, 2020, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Cost-effectiveness analysis of the use of daclatasvir + sofosbuvir + ribavirin (16 weeks and 12 weeks) vs sofosbuvir + ribavirin (16 weeks and 24 weeks) for the treatment of cirrhotic patients affected with hepatitis C virus genotype 3 in Italy

C. Nappi, A. Lazzarin, A. Alberti, 2016, The European Journal of Health Economics.

Intraprocedural contrast-enhanced ultrasound (CEUS) in liver percutaneous radiofrequency ablation: clinical impact and health technology assessment

L. Solbiati, T. Ierace, E. Porazzi, 2014, Insights into Imaging.

Co-Design as Enabling Factor for Patient-Centred Healthcare: A Bibliometric Literature Review

U. Restelli, D. Croce, M. Bonfanti, 2023, ClinicoEconomics and outcomes research : CEOR.

Health technology assessment in the HIV setting: the case of monotherapy.

E. Foglia, E. Porazzi, F. Scolari, 2014, The new microbiologica.

Pressure ulcers management: an economic evaluation.

E. Foglia, E. Porazzi, U. Restelli, 2012, Journal of preventive medicine and hygiene.